CIR
CIR, licence 80028738: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Phyto-Med Inc.
- NPN or DIN-HM
- 80028738
- Status
- Active licence
- Licence date
- 20 December 2011
- Revision date
- 30 November 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Policosanol Source : Saccharum officinarum L. | 5.0 mg | Not calculated |
| Vitis vinifera Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 90 mg | 9.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose, microcristalline, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Utilisé en phytothérapie pour aider à traiter les insuffisances veineuses chroniques et les symptômes qui les accompagnent. Utilisé en phytothérapie pour aider à diminuer les taux élevés des lipides sanguins chez l'adulte.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent. Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte ou si vous allaitez, si vous souffrez de diabètes, si vous prenez des anticoagulants, des salicylates ou des inhibiteurs de protéase. Consulter un praticien de soins de santé avant d'en faire l'usage si vous prenez des médicaments pour la pression artérielle, arythmie, cholestérol élevé, insuffisance cardiaque, anticoagulants ou diurétiques puisque ce produit pourrait interagir avec ces médicaments. Cesser l'utilisation et consulter un praticien de soins de santé si vous avez des symptômes d'hypotension artérielle (pression artérielle basse) tels que des sensations ébrieuses ou de l'étourdissement.
Source
Official Health Canada record, licence 80028738
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.